Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed Prostate Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04114825
What this trial is testing

Study of RV001V in Biochemical Failure Following Curatively Intended Therapy For Localized Prostate Cancer

Who this might be right for
Prostate Cancer Recurrent
RhoVac APS 180
Not applicableLooking for participantsNCT05022914
What this trial is testing

PSMA Guided Approach for bIoCHEmical Relapse After Prostatectomy-PSICHE

Who this might be right for
Prostate CancerBiochemical Relapse Fo Malignant Neoplasm of ProstateProstate Adenocarcinoma+1 more
Azienda Ospedaliero-Universitaria Careggi 180
Large-scale testing (Phase 3)Study completedNCT00055731
What this trial is testing

Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse

Who this might be right for
Prostate Cancer
UNICANCER 413
Early research (Phase 1)Looking for participantsNCT03460977
What this trial is testing

Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

Who this might be right for
Metastatic Castration Resistant Prostate Cancer (mCRPC)Small Cell Lung Cancer (SCLC)Follicular Lymphoma (FL)
Pfizer 453
Early research (Phase 1)Study completedNCT04374240
What this trial is testing

A Clinical Trial of AdNRGM Plus CB1954 in Prostate Cancer

Who this might be right for
Prostate Cancer
University of Birmingham 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07730125
What this trial is testing

Gene-edited T Regulatory Cells (CRG-150) for the Treatment of Relapsed/Refractory Malignancies

Who this might be right for
HR-positive, HER2-negative Breast CancerTNBC - Triple-Negative Breast CancerProstate Cancer
CoRegen, Inc. 67
Not applicableStudy completedNCT03443609
What this trial is testing

Study of 68Ga-HBED-PSMA PET/CT and Conventional Imaging in Occult Biological Relapse Prostate Cancer

Who this might be right for
Prostate Cancer Recurrent
Institut Cancerologie de l'Ouest 130
Early research (Phase 1)Study completedNCT00005634
What this trial is testing

Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+3 more
Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)Not Yet RecruitingNCT05232578
What this trial is testing

Early Salvage Therapy for Patients With Advanced Features for Biochemical Relapse After Radical Prostatectomy for Localized Prostate Carcinoma In Correlation With Supposed Molecular-genetic Parameters of Higher Aggressiveness

Who this might be right for
Prostate Cancer
General University Hospital, Prague 380
Testing effectiveness (Phase 2)Looking for participantsNCT04700332
What this trial is testing

PyL in Patients With High Risk and Biochemically Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
Hoag Memorial Hospital Presbyterian 184
Large-scale testing (Phase 3)Active Not RecruitingNCT06551324
What this trial is testing

Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1).

Who this might be right for
Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Pfizer 600
Not applicableStudy completedNCT02699424
What this trial is testing

Prospective Evaluation of 68-Ga-prostate Specific Membrane Antigen (PSMA)-Positron Emission Tomograph (PET) and Early Prostatic Specific Antigen (PSA) Kinetics During Salvage Radiotherapy for Personalizing the Management of Men With Relapse of Prostate Cancer After Radical Prostatectomy

Who this might be right for
Relapsed Prostate Cancer
Lund University Hospital 100
Testing effectiveness (Phase 2)Study completedNCT04775602
What this trial is testing

Experimental Study to Evaluate the Impact of 18 Fluoro-PSMA (18F-PSMA) PET / CT in the Management of Patients with Prostate Cancer.

Who this might be right for
18F-PSMAProstate Cancer
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 550
Testing effectiveness (Phase 2)Ended earlyNCT00103376
What this trial is testing

Bortezomib With or Without Hormone Therapy in Treating Patients With Relapsed Prostate Cancer

Who this might be right for
Prostate Cancer
Medical University of South Carolina 23
Testing effectiveness (Phase 2)Ended earlyNCT02772562
What this trial is testing

Adjuvant PROSTVAC-V/F in Subjects at High Risk for Relapse After Radical Prostatectomy

Who this might be right for
Prostatic Neoplasms
Medical University of South Carolina 33
Early research (Phase 1)Looking for participantsNCT06999187
What this trial is testing

DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

Who this might be right for
Triple Negative Breast CancerHER2-negative Breast CancerNon Small Cell Lung Cancer+9 more
Dren Bio 96
Early research (Phase 1)Study completedNCT01495663
What this trial is testing

Dose Escalation Study of I-131-CLR1404 in Subjects With Cancer That Does Not Respond to Treatment or Has Returned

Who this might be right for
Cancer
Cellectar Biosciences, Inc. 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06400160
What this trial is testing

Clinical Trial of TB511 in Advanced Solid Tumors

Who this might be right for
NSCLCProstate CancerColorectal Cancer+1 more
Twinpig Biolab, Inc. 12
Testing effectiveness (Phase 2)Ended earlyNCT00780975
What this trial is testing

Aplidin ( Plitidepsin) in Subjects With Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
PharmaMar 8
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Next Page